In a patient during warfarin therapy bleeding is noted then what is the next action, EXCEPT?

NORCET 5 Prelims - Sept 2023 (Shift-2)

Pharmacology

Medium

Appeared in: NORCET 5 Prelims - Sept 2023 (Shift-2)

Explanation

The question asks for the exception among the listed actions for managing warfarin-induced bleeding.
Administering heparin is the incorrect action because heparin is also a potent anticoagulant.
Giving another anticoagulant to a patient who is actively bleeding due to an existing anticoagulant would dangerously increase the risk of severe, uncontrolled hemorrhage.
Heparin works by a different mechanism than warfarin but ultimately also prevents clot formation, so it would exacerbate the bleeding, not treat it.

Option A: Stopping the anticoagulant (warfarin) is a critical and immediate first step to prevent further bleeding by removing the causative agent.
Option B: Administering Vitamin K is a correct and necessary intervention. Vitamin K is the specific antidote for warfarin and works by helping the liver synthesize new clotting factors to restore normal coagulation.
Option D: Administering Fresh Frozen Plasma (FFP) is a correct intervention for severe or life-threatening bleeding. FFP contains all the necessary clotting factors and provides a rapid, temporary reversal of warfarin's effects while waiting for Vitamin K to become effective.

Visual 1: Flowchart - A flowchart illustrating the step-by-step management algorithm for a patient with warfarin-associated bleeding, showing decision points based on INR level and severity of bleeding.
Visual 2: Diagram - A diagram of the coagulation cascade, highlighting where warfarin (inhibiting Vitamin K-dependent factors II, VII, IX, X) and heparin (potentiating antithrombin) act, visually demonstrating they are both anticoagulants.

Clinical Relevance

Nursing practice connection: Use the key finding related to Management of Warfarin-Induced Bleeding to guide bedside assessment, documentation, and the next nursing action.
Nurses must be vigilant in monitoring patients on warfarin for any signs of bleeding, such as hematuria, melena, petechiae, or excessive bruising.
Immediate recognition and reporting of bleeding are crucial for patient safety. The nurse's role includes holding the medication, notifying the physician, and preparing for reversal interventions like Vitamin K or FFP administration.
What if? If the patient had a very high INR (e.g., greater than 10) but no active bleeding, the immediate action would still be to hold the warfarin and administer a small dose of oral Vitamin K, but FFP would likely not be required.

How to Approach the Question

First, identify the question type. This is a negative-framing question using the keyword 'EXCEPT'. This means you are looking for the option that is NOT a correct action.
Analyze the clinical scenario: a patient is on warfarin and is bleeding.
Recall the function of warfarin (an anticoagulant) and the standard protocol for managing its major side effect, bleeding.
Evaluate each option: 'Stop Anticoagulant' is logical. 'Administer Vitamin-K' is the known antidote. 'Administer FFP' is for severe bleeding. 'Administer Heparin' is another anticoagulant.
The option that stands out as incorrect and dangerous is administering another anticoagulant (heparin) to a bleeding patient. This makes it the correct answer to the 'EXCEPT' question.

Concept Tested & Keywords

Concept Tested: Management of Warfarin-Induced Bleeding
Stem keywords: warfarin therapy, bleeding
Lead-in keywords: EXCEPT
Negative lead-in flag: This is a negative lead-in question, asking for the action that should NOT be taken.

Q55VGLy9-RD8WoZpkWuVRP